BESSEMER GROUP INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1
-99.9%
17
+30.8%
0.00%
Q2 2020$1,0000.0%130.0%0.00%
Q1 2020$1,0000.0%13
-13.3%
0.00%
Q4 2019$1,0000.0%15
+7.1%
0.00%
Q3 2019$1,000
-50.0%
14
-6.7%
0.00%
Q1 2019$2,000
-99.8%
15
-99.8%
0.00%
-100.0%
Q4 2018$891,000
-47.5%
6,570
+6.3%
0.00%
-33.3%
Q3 2018$1,696,000
+36.4%
6,179
+3.0%
0.01%
+20.0%
Q2 2018$1,243,000
+25.4%
6,0000.0%0.01%
+25.0%
Q1 2018$991,000
+16.7%
6,000
-3.2%
0.00%
+33.3%
Q4 2017$849,000
+72.2%
6,200
+71.2%
0.00%
+50.0%
Q3 2017$493,000
+16333.3%
3,621
+17142.9%
0.00%
Q2 2017$3,000
+50.0%
210.0%0.00%
Q1 2017$2,000
-75.0%
21
-73.1%
0.00%
Q4 2016$8,000
-98.6%
78
-98.6%
0.00%
-100.0%
Q3 2016$565,000
+5036.4%
5,542
+5990.1%
0.00%
Q2 2016$11,000
-38.9%
91
-45.5%
0.00%
Q1 2016$18,000
-99.2%
167
-99.2%
0.00%
-100.0%
Q4 2015$2,374,000
+26.6%
21,8940.0%0.01%
+18.2%
Q3 2015$1,875,000
+37400.0%
21,894
+45512.5%
0.01%
Q2 2015$5,000
+25.0%
480.0%0.00%
Q1 2015$4,000480.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders